Quantcast
Channel: Defymed – MassDevice
Browsing latest articles
Browse All 4 View Live

Image may be NSFW.
Clik here to view.

JDRF backs Defymed for artificial pancreas study

French biotech developer Defymed said today that it is partnering with the Junior Diabetes Research Foundation to fund studies of the company’s Mailpan bioartifical pancreas. The Mailpan device is...

View Article



Image may be NSFW.
Clik here to view.

Defymed partners with Semma Therapeutics on bio-artificial pancreas

French biotech developer Defymed said today it inked a collaborative deal with American biotech company Semma Therapeutics to support the continued development of a bio-artificial pancreas to treat...

View Article

Artificial pancreas: These companies are racing to make one

Medical device companies are close to achieving the holy grail of diabetes treatment: a combined glucose sensor, control algorithm and insulin infusion device that effectively acts as an “artificial...

View Article

Image may be NSFW.
Clik here to view.

Defymed reveals development of novel insulin delivery device

France-based medtech company Defymed said today that it’s developing a novel insulin delivery device which it hopes to bring to market by the end of 2020. The company’s device, ExOlin, uses a...

View Article
Browsing latest articles
Browse All 4 View Live




Latest Images